Cargando…
ARHGAP25 expression in colorectal cancer as a biomarker associated with favorable prognosis
Although progress has been made in the early diagnosis of colorectal cancer (CRC) and in the systemic therapy of patients with CRC, the prognosis for advanced CRC remains poor. Our previous study demonstrated that ARHGAP25 overexpression significantly inhibits CRC cell growth, invasion and migration...
Autores principales: | Zhang, Yue, Lin, Yi, Zhu, Yingjie, Zhang, Xiaoyun, Tao, Li, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892469/ https://www.ncbi.nlm.nih.gov/pubmed/35251635 http://dx.doi.org/10.3892/mco.2022.2517 |
Ejemplares similares
-
Analysis of ARHGAP4 Expression With Colorectal Cancer Clinical Characteristics and Prognosis
por: Fu, Ming-sheng, et al.
Publicado: (2022) -
The tumor suppressive roles of ARHGAP25 in lung cancer cells
por: Xu, Ke, et al.
Publicado: (2019) -
DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival
por: Hu, Sheng, et al.
Publicado: (2021) -
SRSF3 functions as an oncogene in colorectal cancer by regulating the expression of ArhGAP30
por: Wang, Ji-Lin, et al.
Publicado: (2020) -
Lacking ARHGAP25 mitigates the symptoms of autoantibody-induced arthritis in mice
por: Czárán, Domonkos, et al.
Publicado: (2023)